Walleye Capital
TSVT

Walleye Capital’s 2seventy bio TSVT Stock Holding History

Walleye Capital’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-75,307
Closed -$762K – 5340
2023
Q2 		$762K Buy
+75,307
New +$797K ﹤0.01% 2077
2023
Q1 		– Sell
-30,671
Closed -$287K – 4379
2022
Q4 		$287K Buy
30,671
+14,576
+91% +$206K 0.01% 1822
2022
Q3 		$234K Buy
+16,095
New +$239K ﹤0.01% 2010
2022
Q1 		– Sell
-23,110
Closed -$592K – 2598
2021
Q4 		$592K Buy
+23,110
New +$721K 0.02% 882

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Walleye Capital's TSVT Position: Q3 2023 in Review

Walleye Capital sold out of 2seventy bio (TSVT) in Q3 2023, closing a stake of 75,307 shares — an estimated $762K sold.

Walleye Capital first reported a position in TSVT in Q4 2021 and held it in 4 quarters. The position peaked at $762K in Q2 2023. 145 funds tracked by Wall St. Rank hold TSVT as of Q3 2023.

  • Walleye Capital reported no remaining 2seventy bio position as of Q3 2023 after selling out during the quarter.
  • Walleye Capital sold 75,307 2seventy bio shares in Q3 2023, an estimated $762K.
  • Walleye Capital first reported a position in 2seventy bio in Q4 2021 and held it in 4 quarters.
  • Walleye Capital's 2seventy bio position peaked at $762K in Q2 2023.
  • 145 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.